New Two-Drug attack on tough cancers shows early promise
Disease control
Completed
This early-stage study tested the safety of combining two experimental drugs, vobramitamab duocarmazine and lorigerlimab, in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and see how the body processes …
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC